Scott A. Segel

Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes

Scott A. Segel, Deanna S. Paramore, Philip E. Cryer · Diabetes · 2002 · 339 citations · Full text

Medicine, Endocrinology, Diabetology +16

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial

Roy W. Beck, Tonya D. Riddlesworth, Katrina J. Ruedy et al. · The Lancet Diabetes & Endocrinology · 2017 · 119 citations

Medicine, Internal Medicine, Diabetology +14

Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia

Scott A. Segel, Carmine G. Fanelli, Carmen S. Dence et al. · Diabetes · 2001 · 109 citations · Full text

Medicine, Endocrinology, Neuroscience +16

Symptomatic Anti-Parkinsonian Effects of Monoamine Oxidase-B Inhibition: Comparison of Selegiline and Lazabemide

Peter A. LeWitt, Scott A. Segel, Kathie Mistura et al. · Clinical Neuropharmacology · 1993 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +15